Midwife-Led Home-Based Postpartum Follow-up Program
Effectiveness of a Midwife-Led Home-Based Postpartum Follow-up Program on Breastfeeding Self-Efficacy, Sleep Quality, and Maternal Attachment: A Randomized Controlled Trial
1 other identifier
interventional
98
1 country
1
Brief Summary
This randomized controlled trial evaluated whether a structured, midwife-led home-based postpartum follow-up program could improve breastfeeding self-efficacy, postpartum sleep quality, and maternal attachment among postpartum women. A total of 98 women were randomly assigned in a 1:1 ratio to either the intervention group or the control group. In addition to routine postpartum care, women in the intervention group received an individual education session before hospital discharge, a home visit during the second postpartum week, and telephone follow-up during the fourth postpartum week. Women in the control group received routine postpartum care. Breastfeeding self-efficacy, postpartum sleep quality, and maternal attachment were assessed at baseline and at six weeks postpartum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2026
CompletedFirst Submitted
Initial submission to the registry
August 14, 2026
CompletedFirst Posted
Study publicly available on registry
August 19, 2026
CompletedAugust 19, 2026
August 1, 2026
6 months
August 14, 2026
August 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Breastfeeding Self-Efficacy Scale Score
Breastfeeding self-efficacy was assessed using the 33-item Breastfeeding Self-Efficacy Scale. Each item is scored from 1 to 5, producing a total score ranging from 33 to 165. Higher scores indicate greater breastfeeding self-efficacy. Change from baseline to six weeks postpartum was evaluated.
Baseline (within 48 hours postpartum) and six weeks postpartum
Secondary Outcomes (3)
Change in Postpartum Sleep Quality Scale Score
Baseline (within 48 hours postpartum) and six weeks postpartum
Change in Maternal Attachment Inventory Score
Baseline (within 48 hours postpartum) and six weeks postpartum
Exclusive Breastfeeding Status
Six weeks postpartum
Study Arms (2)
Structured Midwife-Led Postpartum Follow-up Program
EXPERIMENTALParticipants received routine postpartum care plus a structured, midwife-led follow-up program consisting of an individual education session before hospital discharge, a home visit during the second postpartum week, and telephone follow-up during the fourth postpartum week.
Routine Postpartum Care
ACTIVE COMPARATORParticipants received the routine postpartum care and discharge education provided by the hospital. They did not receive the structured home visit or telephone follow-up program during the study period.
Interventions
The program included a 15-minute individual education session before hospital discharge, a home visit of approximately 30 minutes during the second postpartum week, and telephone follow-up during the fourth postpartum week. The program addressed breastfeeding technique, positioning and attachment, management of breastfeeding problems, postpartum self-care, sleep hygiene, maternal-infant interaction, and individualized problem-solving.
Routine postpartum care and standard discharge education were provided according to the hospital's usual clinical practice.
Eligibility Criteria
You may qualify if:
- Aged 18 years or older Delivered a singleton live-born infant at term (37 weeks of gestation or later) Intended to breastfeed Able to communicate in Turkish Provided written informed consent Both the mother and infant were medically stable and eligible for discharge following routine postpartum care
You may not qualify if:
- A maternal or infant medical condition contraindicating breastfeeding A severe maternal or infant complication requiring prolonged hospitalization or intensive care A diagnosed maternal psychiatric disorder that could interfere with participation Inability to participate in the scheduled follow-up procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Elazig Fethi Sekin City Hospital
Elazig, Turkey, Elâzığ, 23280, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Participants and the researcher delivering the intervention were not masked because of the nature of the intervention. The statistician who performed the analyses was blinded to group allocation.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 14, 2026
First Posted
August 19, 2026
Study Start
February 12, 2026
Primary Completion
July 28, 2026
Study Completion
July 28, 2026
Last Updated
August 19, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Beginning after publication of the study results, with no predetermined end date.
- Access Criteria
- Researchers who submit a methodologically sound proposal may request access by contacting the corresponding author. Requests will be evaluated in accordance with participant confidentiality and the conditions of the ethics approval.
De-identified individual participant data underlying the findings reported in this article will be available from the corresponding author upon reasonable request. Data will be shared subject to ethical and confidentiality considerations.